Five companies will witness the expiration of their shareholder lock-in periods this week, making shares worth nearly ₹25,000 crore eligible for trading. The companies include Midwest Ltd., Capital Infra Trust Ltd., KSH International Ltd., Laxmi Dental Ltd., and Anthem Biosciences Ltd. While the shares become eligible for trading, the end of lock-in periods does not guarantee that all shares will be sold in the open market.

Monday Lock-in Expiries

Three companies will see their respective lock-in periods conclude on Monday, January 19, with varying percentages of their outstanding equity becoming tradeable.

Midwest Ltd. will see its three-month lock-in period conclude, freeing up 0.60 million shares representing 2% of its outstanding equity. The stock currently trades 34% above its IPO price of ₹1,065 per share, with the unlocked shares valued at ₹85.62 crore.

Capital Infra Trust Ltd. faces the largest proportion of equity unlocking on Monday, with 74.70 million units or 27% of outstanding equity becoming tradeable as the one-year lock-in period expires. These units are worth ₹552.00 crore, though the stock trades 26% below its issue price of ₹100 per unit.

KSH International Ltd. will have 2.80 million shares worth ₹102.30 crore become eligible for trading, representing 4% of its outstanding equity. The company's shares currently trade 5% below their issue price of ₹384 per share.

Tuesday and Thursday Expiries

Laxmi Dental Ltd. will see its one-year lock-in period end on Tuesday, January 20, releasing 7.10 million shares or 13% of outstanding equity worth ₹172.20 crore. The stock has experienced significant value erosion, currently trading 43% below its issue price of ₹428.

Anthem Biosciences Dominates Unlock Value

Anthem Biosciences Ltd. accounts for the majority of this week's unlock value, with 387.20 million shares or 69% of its outstanding equity becoming tradeable on Thursday, January 22. The six-month lock-in period expiry will free up shares worth ₹23,619.00 crore. The company's shares currently trade 7% above their issue price of ₹570.

The substantial unlock from Anthem Biosciences represents approximately 94% of the total ₹25,000 crore worth of shares becoming eligible for trading across all five companies this week.

Indian equity markets witnessed mixed corporate earnings and significant business developments as several major companies announced their third-quarter results and strategic initiatives. The earnings season has brought a combination of profit declines, modest growth, and notable corporate actions across various sectors.

Financial Services Sector Shows Mixed Performance

The financial services sector displayed varied performance during the December quarter. Angel One, the stock brokerage firm, reported disappointing results with consolidated net profit declining 4% year-on-year to ₹269 crore in the third quarter. However, the company's board approved shareholder-friendly measures including an interim dividend of ₹23 per share and a stock split in the ratio of 1:10.

HDFC Life Insurance demonstrated muted bottomline growth with standalone profit after tax rising marginally by 1% year-on-year to ₹421 crore, compared with ₹415 crore in the same period last year. The insurance company's net premium income showed better momentum, growing 9% year-on-year to ₹18,242 crore during the quarter, up from ₹16,771 crore a year ago.

Technology Sector Faces Headwinds

The information technology sector presented challenging results during the third quarter. Infosys, India's second-largest IT services company, reported a 2% year-on-year decline in consolidated net profit at ₹6,654 crore in the third quarter, compared with ₹6,806 crore in the corresponding period last year. Despite the profit decline, revenue from operations increased 9% year-on-year to ₹45,479 crore.

L&T Technology Services, a mid-tier IT services company, experienced a 6% year-on-year decline in consolidated net profit at ₹303 crore in the third quarter, down from ₹322 crore in the year-ago period. However, excluding the impact of labour codes, the company reported profit growth of 2% year-on-year to ₹329 crore.

Major Corporate Developments and Strategic Initiatives

Several companies announced significant business developments and strategic acquisitions. Indian Hotels Company (IHCL), backed by the Tata Group, entered into a share subscription agreement to acquire approximately 51% shareholding in Brij Hospitality for an amount not exceeding ₹225 crore. The transaction will be executed directly or through IHCL's subsidiaries ANK and Pride, subject to fulfillment of certain condition precedents.

Infrastructure and Energy Sector Achievements

The infrastructure and energy sectors witnessed notable project completions and new order wins. Cochin Shipyard Limited delivered the first vessel in the HS EcoFreighter series of Multi-Purpose Vessels to Germany's HS Schiffahrts. The vessel, designed by Groot Ship Design of Netherlands and constructed at CSL, is part of an eight-vessel order worth approximately ₹110 crore each.

Larsen & Toubro's heavy civil infrastructure business vertical secured a large order from Torrent Energy Storage Solutions for constructing the 3000 MW Saidongar-1 Pumped Storage Project in Maharashtra. Meanwhile, state-run power giant NTPC announced that its step-down arm NTPC Renewable Energy began commercial supply of 300 MW electricity from its 500 MW Bhadla solar project in Rajasthan from January 13.

Regulatory Approvals and Market Outlook

Zydus Lifesciences received final approval from the US health regulator for its generic version of Eltrombopag tablets, indicated for treating thrombocytopenia in specific blood disorders. This approval strengthens the company's presence in the US pharmaceutical market.

The mixed earnings results and corporate developments reflect the varied performance across sectors, with financial services showing divergent trends, technology facing margin pressures, and infrastructure companies securing significant project wins. These developments will likely influence investor sentiment and trading patterns in the coming sessions.